Traditional Chinese medicine treatment for abemaciclib‑associated diarrhea based on six‑channel syndrome differentiation

ZHU Mengdie; SHI Youyang; LI Feifei; LIU Sheng

doi:10.16305/j.1007-1334.2025.z20240627009

您当前的位置：

首页 >

文章列表页 >

Traditional Chinese medicine treatment for abemaciclib‑associated diarrhea based on six‑channel syndrome differentiation

更新时间：2025-05-07

- Traditional Chinese medicine treatment for abemaciclib‑associated diarrhea based on six‑channel syndrome differentiation
- Shanghai Journal of Traditional Chinese Medicine Vol. 59, Issue 5, Pages: 29-32(2025)
- 作者机构：
  
  1.上海中医药大学附属龙华医院（上海　200032）
  2.上海中医药大学（上海　201203）
- 作者简介：
- 基金信息：
- DOI：10.16305/j.1007-1334.2025.z20240627009
  CLC：
- Received：27 June 2024，
  
  Published：10 May 2025
- 稿件说明：
移动端阅览
朱梦蝶,史有阳,李斐斐,等.从六经辨证角度探析阿贝西利相关腹泻的中医药治疗[J].上海中医药杂志,2025,59(5):29-32.

ZHU Mengdie,SHI Youyang,LI Feifei,et al.Traditional Chinese medicine treatment for abemaciclib‑associated diarrhea based on six‑channel syndrome differentiation[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(5):29-32.
朱梦蝶,史有阳,李斐斐,等.从六经辨证角度探析阿贝西利相关腹泻的中医药治疗[J].上海中医药杂志,2025,59(5):29-32. DOI： 10.16305/j.1007-1334.2025.z20240627009.

ZHU Mengdie,SHI Youyang,LI Feifei,et al.Traditional Chinese medicine treatment for abemaciclib‑associated diarrhea based on six‑channel syndrome differentiation[J].Shanghai Journal of Traditional Chinese Medicine,2025,59(5):29-32. DOI： 10.16305/j.1007-1334.2025.z20240627009.

摘要

以阿贝西利为主的细胞周期依赖性激酶（CDK）4/6抑制剂联合内分泌治疗已成为激素受体阳性晚期乳腺癌患者的一线治疗方案，然而阿贝西利胃肠道毒副作用明显，严重影响患者的生活质量。从六经辨证的角度分析阿贝西利相关腹泻的病机传变规律，根据疾病不同阶段合理选择方药，可有效改善患者的腹泻症状。并附验案1则。

Abstract

Cyclin-dependent kinase 4/6 （CDK4/6） inhibitors such as abemaciclib， when combined with endocrine therapy， have become the first-line treatment for patients with hormone receptor-positive advanced breast cancer. However， abemaciclib often causes gastrointestinal toxicities and adverse effects， which significantly impair patients' quality of life. Therefore， this article explores the pathogenesis and progression of abemaciclib-associated diarrhea based on six-channel syndrome differentiation. Our analysis suggests that tailoring herbal formulas and treatments to specific stages of the disease can effectively alleviate diarrhea symptoms. A confirmed case is presented for reference.

关键词

Keywords

references

SUNG H ， FERLAY J ， SIEGEL R L ， et al . Global cancer statistics 2020：GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries ［J］. CA Cancer J Clin ， 2021 ， 71 （ 3 ）： 209 - 249 .

Jr SLEDGE G W ， TOI M ， NEVEN P ， et al . The effect of abemaciclib plus fulvestrant on overall survival in hormone receptor-positive，ERBB2-negative breast cancer that progressed on endocrine therapy-MONARCH 2： a randomized clinical trial ［J］. JAMA Oncol ， 2019 ， 6 ： 116 - 124 .

ZHANG Q ， SHEN K ， SONG C G ， et al . Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive，HER2-，high-risk early breast cancer： 5-year Chinese population analysis of the phase Ⅲ randomized monarchE study ［J］. Ther Adv Med Oncol ， 2024 ， 16 ： 17588359241286775 .

LAM W ， BUSSOM S ， GUAN F ， et al . The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity ［J］. Sci Transl Med ， 2010 ， 2 （ 45 ）： 45ra59 .

钱丽君，金梦洁，吕欣妮，等 . 基于“六经辨证，治从三阴”论治化疗相关性腹泻［J］. 亚太传统医药， 2023 ， 19 （ 4 ）： 215 - 218 .

史莎莎，余成浩 . 《伤寒论》太阳病下利条文及方药整理分析［J］. 新中医， 2021 ， 53 （ 14 ）： 6 - 9 .

田明敏 . 《伤寒论》黄芩汤方证研究［D］. 南京：南京中医药大学， 2018 .

陈文露，陈所银，黄炜乾，等 . UPLC法同时测定黄芩汤中5种成分［J］. 中成药， 2023 ， 45 （ 6 ）： 1799 - 1802 .

侯晓杰，张建锋，侯长周，等 . 黄芩苷药理活性和作用机制研究进展［J］. 药物评价研究， 2024 ， 47 （ 11 ）： 2688 - 2696 .

王欣，朱敏，董思晶，等 . 芍药苷对结肠炎小鼠肠道菌群及胆汁酸代谢的调节作用［J］. 药学学报， 2021 ， 56 （ 7 ）： 1811 - 1819 .

干丹，杨豪杰，黄冕，等 . 胆汁酸代谢及其受体调节溃疡性结肠炎肠道免疫及中药干预研究进展［J］. 上海中医药杂志， 2023 ， 57 （ 9 ）： 96 - 100 .

高聚伟，徐凯，冉冉，等 . 龙葵碱对肝癌Treg细胞介导的肿瘤免疫逃逸的影响［J］. 中国现代医生， 2021 ， 59 （ 18 ）： 35 - 38 .

李佳轩，罗斌，冯茜，等 . 田建辉治疗恶性肿瘤及其合并症常用药对-药组撷菁［J］. 上海中医药杂志， 2024 ， 58 （ 12 ）： 95 - 99 .

曹慧君，杨姣 . 地榆升白片联合PEG-rhG-CSF治疗恶性肿瘤化疗后中性粒细胞减少的临床价值［J］. 实用中西医结合临床， 2024 ， 24 （ 5 ）： 48 - 50 .

穆杰，冯全生，陈云惠，等 . 关于《伤寒论》由诊断层面“辨病、辨证、辨症”与论治层面“类方、方、药”构建的诊治体系的思考［J］. 环球中医药， 2022 ， 15 （ 8 ）： 1359 - 1362 .

Views

下载量

CSCD

CNKI被引量

Alert me when the article has been cited

提交

Tools

Publicity Resources

Investigation of pathogenesis and treatment of airway remodeling in asthma based on collateral diseases theory

Discussion on pathogenesis and intervention strategies of tumor metabolic reprogramming from the "spleen⁃metabolism" correlation in traditional Chinese medicine

Wang Qingqi's experience in treating spleen and stomach diseases by using "activating yang method"

Study on prevention and treatment of acute exacerbation of COPD with traditional Chinese medicine based on regulation of intestinal flora

Effect of electroacupuncture on pain threshold and activation of spinal microglia M1/M2 in rats with neuropathic pain

Related Author

ZHANG Yada

CHEN Yiren

TANG Binqing

ZHANG Wei

DAI Yining

SUN Yuhan

XIAO Jiao

YUAN Yamin

Related Institution

Department of Pulmonary Disease， Shanghai Municipal Hospital of Traditional Chinese Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

School of Clinical Medicine， Shanghai Municipal Hospital of Traditional Chinese Medicine， Shanghai University of Traditional Chinese Medicine

Department of Pulmonary Disease， Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

First Clinical School， Shandong University of Traditional Chinese Medicine

Department of Oncology， The Affiliated Hospital of Shandong University of Traditional Chinese Medicine

⁰